New Findings Suggest Stopping Statins May Be Safe for Certain Older Adults
Recent clinical findings indicate that stopping statin therapy could be a viable option for older individuals who lack a prior history of cardiovascular disease, though personal health evaluations remain essential.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- Study published in the New England Journal of Medicine and presented at the American Heart Association Scientific Sessions 2026.
- Involved 1,880 participants aged 70 and older with at least two chronic conditions but no prior cardiovascular events.
- Results showed noninferiority in event-free survival, though a slight numerical difference in cardiovascular events was noted.
Stopping statins for primary prevention appears largely safe among older adults who have no prior history of heart disease, according to a clinical investigation published in the New England Journal of Medicine. The findings were simultaneously presented at the American Heart Association Scientific Sessions 2026 in Chicago. Led by Dr. Nicolas Rodondi of the University of Bern in Switzerland, the study investigated whether halting these lipid-lowering drugs altered the timeline for initial cardiovascular events among individuals aged 70 and older managing multiple chronic conditions.
Study Design and Results
The trial evaluated 1,880 participants randomly assigned either to stop or to maintain their statin and lipid-lowering medications. Over a median monitoring duration of 103 weeks, investigators observed event-free survival differences that met the statistical threshold for noninferiority. Specifically, 12.7% of participants who stopped the medication experienced a nonfatal myocardial infarction, nonfatal ischemic stroke, or death from any cause, compared to 9.2% in the group that continued treatment. Serious adverse events were recorded in 43.0% of the discontinuation group and 39.8% of the continuation cohort.
Expert Perspectives and Limitations
While the study demonstrates statistical noninferiority, researchers emphasize the nuances involved in clinical care. Dr. Rita F. Redberg, a co-author from the University of California, San Francisco, noted that the minor elevation in cardiovascular events prevents a blanket recommendation for halting the medication. Instead, she highlights the necessity of collaborative discussions between patients and clinicians to determine the best course of action. These observational parameters remind us that findings should be interpreted with care regarding sample specifics and individual health backgrounds. Always talk to a doctor for personal medical decisions.
Source Medical Xpress — medicalxpress.com/news/2026-11-aha-discontinuing-statins-noninferior-ol… ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…